Our scientific advisory board plays an important role as we aim to develop the best medicines possible from our intellectual property. Our Scientific Advisory Board meets twice a year to discuss and evaluate potential opportunities and guide our scientists as they work to develop new and improved versions of our existing products.
1982 Nobel Laureate in Physiology or Medicine
Click here for Martine Rothblatt's tribute to Sir John.

Chairman of the Scientific Advisory Board
1976 Nobel Laureate in Physiology or Medicine
Fox Chase Distinguished Scientist,
Fox Chase Cancer Center

Professor of Medicine, Radiology, and Surgery
Director, Division of Cardiovascular Disease
Vice Chair, Administration and Finance
Department of Medicine
University of Alabama at Birmingham

Professor of Glycobiology
Director of the Glycobiology Institute
University of Oxford
President, Institute of Biology
Chancellor for Health Affairs
President and Chief Executive Officer
Duke University Health System
James B. Duke Professor of Medicine and
Director of Molecular and Genomic Vascular Biology
Duke University

Professor of Medicine, Pulmonary and Critical Care Division
University of California, San Diego Medical Center

Founding President and President Emeritus
Morehouse School of Medicine
Former Secretary of United States
Department of Health and Human Services

Distinguished Service Professor of Surgery, University of Pittsburgh School of Medicine
Thomas E. Starzl Transplantation Institute, University of Pittsburgh and the University of Pittsburgh Medical Center (UPMC).

Professor of Cardiothoracic Surgery
National Heart and Lung Institute
Imperial College London
**Member of United Therapeutics' Board of Directors